Hawaii Biotech plans to file for bankruptcy

12/13/2009 | American City Business Journals

Hawaii Biotech has announced its plan to file for Chapter 11 reorganization in U.S. Bankruptcy Court. The company said the move is meant to allow it "to continue its current and planned human clinical trials, keep its staff in place, pursue funding and protect current investors." The company currently is conducting clinical studies of vaccines for West Nile virus and dengue fever.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA